vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and QUINSTREET, INC (QNST). Click either name above to swap in a different company.
QUINSTREET, INC is the larger business by last-quarter revenue ($287.8M vs $180.9M, roughly 1.6× AVANOS MEDICAL, INC.). QUINSTREET, INC runs the higher net margin — 17.4% vs -0.7%, a 18.2% gap on every dollar of revenue. On growth, QUINSTREET, INC posted the faster year-over-year revenue change (1.9% vs 0.7%). AVANOS MEDICAL, INC. produced more free cash flow last quarter ($21.3M vs $20.7M). Over the past eight quarters, QUINSTREET, INC's revenue compounded faster (53.2% CAGR vs 4.4%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
QUINSTREET, INCQNSTEarnings & Financial Report
QuinStreet, Inc. is a publicly traded online marketing company based in Foster City, California. The company helps generate web traffic for clients by acquiring popular domain names.
AVNS vs QNST — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $287.8M |
| Net Profit | $-1.3M | $50.2M |
| Gross Margin | 47.5% | 9.6% |
| Operating Margin | 1.4% | 0.4% |
| Net Margin | -0.7% | 17.4% |
| Revenue YoY | 0.7% | 1.9% |
| Net Profit YoY | 99.7% | 3342.5% |
| EPS (diluted) | $-0.02 | $0.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $180.9M | $287.8M | ||
| Q3 25 | $177.8M | $285.9M | ||
| Q2 25 | $175.0M | — | ||
| Q1 25 | $167.5M | $269.8M | ||
| Q4 24 | $179.6M | $282.6M | ||
| Q3 24 | $170.4M | $279.2M | ||
| Q2 24 | $171.7M | $198.3M | ||
| Q1 24 | $166.1M | $168.6M |
| Q4 25 | $-1.3M | $50.2M | ||
| Q3 25 | $-1.4M | $4.5M | ||
| Q2 25 | $-76.8M | — | ||
| Q1 25 | $6.6M | $4.4M | ||
| Q4 24 | $-397.3M | $-1.5M | ||
| Q3 24 | $4.3M | $-1.4M | ||
| Q2 24 | $1.8M | $-2.2M | ||
| Q1 24 | $-900.0K | $-7.0M |
| Q4 25 | 47.5% | 9.6% | ||
| Q3 25 | 48.4% | 9.4% | ||
| Q2 25 | 52.6% | — | ||
| Q1 25 | 53.6% | 10.3% | ||
| Q4 24 | 54.6% | 9.5% | ||
| Q3 24 | 54.5% | 10.2% | ||
| Q2 24 | 55.7% | 8.8% | ||
| Q1 24 | 57.1% | 8.5% |
| Q4 25 | 1.4% | 0.4% | ||
| Q3 25 | 0.1% | 1.7% | ||
| Q2 25 | -42.6% | — | ||
| Q1 25 | 6.1% | 1.8% | ||
| Q4 24 | -233.0% | -0.5% | ||
| Q3 24 | 7.0% | -0.4% | ||
| Q2 24 | 3.7% | -0.7% | ||
| Q1 24 | 2.4% | -3.2% |
| Q4 25 | -0.7% | 17.4% | ||
| Q3 25 | -0.8% | 1.6% | ||
| Q2 25 | -43.9% | — | ||
| Q1 25 | 3.9% | 1.6% | ||
| Q4 24 | -221.2% | -0.5% | ||
| Q3 24 | 2.5% | -0.5% | ||
| Q2 24 | 1.0% | -1.1% | ||
| Q1 24 | -0.5% | -4.2% |
| Q4 25 | $-0.02 | $0.87 | ||
| Q3 25 | $-0.03 | $0.08 | ||
| Q2 25 | $-1.66 | — | ||
| Q1 25 | $0.14 | $0.08 | ||
| Q4 24 | $-8.64 | $-0.03 | ||
| Q3 24 | $0.09 | $-0.02 | ||
| Q2 24 | $0.04 | $-0.04 | ||
| Q1 24 | $-0.02 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $107.0M |
| Total DebtLower is stronger | $90.3M | — |
| Stockholders' EquityBook value | $778.2M | $294.4M |
| Total Assets | $1.1B | $493.0M |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.8M | $107.0M | ||
| Q3 25 | $70.5M | $101.3M | ||
| Q2 25 | $90.3M | — | ||
| Q1 25 | $97.0M | $81.8M | ||
| Q4 24 | $107.7M | $57.8M | ||
| Q3 24 | $89.0M | $25.0M | ||
| Q2 24 | $92.2M | $50.5M | ||
| Q1 24 | $75.8M | $39.6M |
| Q4 25 | $90.3M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $95.7M | — | ||
| Q1 25 | $98.0M | — | ||
| Q4 24 | $125.3M | — | ||
| Q3 24 | $152.6M | — | ||
| Q2 24 | $164.9M | — | ||
| Q1 24 | $167.2M | — |
| Q4 25 | $778.2M | $294.4M | ||
| Q3 25 | $778.0M | $246.7M | ||
| Q2 25 | $776.3M | — | ||
| Q1 25 | $839.4M | $235.5M | ||
| Q4 24 | $828.5M | $224.3M | ||
| Q3 24 | $1.2B | $219.8M | ||
| Q2 24 | $1.2B | $216.8M | ||
| Q1 24 | $1.2B | $215.0M |
| Q4 25 | $1.1B | $493.0M | ||
| Q3 25 | $1.1B | $442.6M | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $1.1B | $417.2M | ||
| Q4 24 | $1.2B | $409.6M | ||
| Q3 24 | $1.7B | $401.2M | ||
| Q2 24 | $1.7B | $368.5M | ||
| Q1 24 | $1.7B | $349.3M |
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.12× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.14× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | $21.6M |
| Free Cash FlowOCF − Capex | $21.3M | $20.7M |
| FCF MarginFCF / Revenue | 11.8% | 7.2% |
| Capex IntensityCapex / Revenue | 3.8% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 0.43× |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | $106.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $21.6M | ||
| Q3 25 | $14.0M | $19.6M | ||
| Q2 25 | $6.8M | — | ||
| Q1 25 | $25.7M | $30.1M | ||
| Q4 24 | $57.9M | $38.7M | ||
| Q3 24 | $23.0M | $-13.7M | ||
| Q2 24 | $27.8M | $16.6M | ||
| Q1 24 | $-8.0M | $4.1M |
| Q4 25 | $21.3M | $20.7M | ||
| Q3 25 | $7.0M | $18.4M | ||
| Q2 25 | $-4.2M | — | ||
| Q1 25 | $19.0M | $29.5M | ||
| Q4 24 | $53.1M | $38.2M | ||
| Q3 24 | $20.0M | $-14.1M | ||
| Q2 24 | $21.9M | $15.4M | ||
| Q1 24 | $-12.1M | $2.9M |
| Q4 25 | 11.8% | 7.2% | ||
| Q3 25 | 3.9% | 6.4% | ||
| Q2 25 | -2.4% | — | ||
| Q1 25 | 11.3% | 10.9% | ||
| Q4 24 | 29.6% | 13.5% | ||
| Q3 24 | 11.7% | -5.1% | ||
| Q2 24 | 12.8% | 7.8% | ||
| Q1 24 | -7.3% | 1.7% |
| Q4 25 | 3.8% | 0.3% | ||
| Q3 25 | 3.9% | 0.4% | ||
| Q2 25 | 6.3% | — | ||
| Q1 25 | 4.0% | 0.2% | ||
| Q4 24 | 2.7% | 0.2% | ||
| Q3 24 | 1.8% | 0.2% | ||
| Q2 24 | 3.4% | 0.6% | ||
| Q1 24 | 2.5% | 0.7% |
| Q4 25 | — | 0.43× | ||
| Q3 25 | — | 4.32× | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.89× | 6.82× | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.35× | — | ||
| Q2 24 | 15.44× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
QNST
| Financial Service | $216.8M | 75% |
| Home Services And Other Revenue | $71.0M | 25% |
